# Seattle Reproductive Medicine, Inc., P.S. – FDA Inspection, Feb 28, 2020

Source: https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/ee6e5e84-45a5-4ea0-8442-7c60c79e7acc
Source feed: FDA_Inspections

> FDA inspection 1121341 of Seattle Reproductive Medicine, Inc., P.S., February 28, 2020. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121341
- Company Name: Seattle Reproductive Medicine, Inc., P.S.
- Inspection Date: 2020-02-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1275096 - 2025-07-02
- FDA Inspection 1019977 - 2017-07-11
- FDA Inspection 910138 - 2015-01-20
- FDA Inspection 810062 - 2012-12-10
- FDA Inspection 558831 - 2009-01-14

Company: https://www.keypedia.com/companies/seattle-reproductive-medicine-inc-ps/26f70cff-dd9c-4142-8c98-9ca9f2e83f56

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d